Antifungal agents, Part 11. Biphenyl analogues of naftifine: synthesis and antifungal activities. 1995

G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
Dipartimento di Studi di Chimica e Tecnologia delle Sostanze Biologicamente Attive, Università di Roma La Sapienza, Roma, Italy.

A series of naftifine analogues having the biphenyl instead of the naphthyl moiety have been synthesized in a search devoted to study bioanalogues of clinically efficacious antifungal agents. The new derivatives were tested against Candida albicans by the direct contact method. They were also assayed against Gram-positive and Gram-negative bacteria and against some isolates of plant pathogenic fungi. Derivatives 8a, 8c, and 9a were found to be active against Candida albicans, derivative 5a was active against E. coli, a very resistant species to antimycotic agents, and derivatives 8a and 8b inhibited the plant pathogenic Rhizoctonia solani.

UI MeSH Term Description Entries
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000499 Allylamine Possesses an unusual and selective cytotoxicity for VASCULAR SMOOTH MUSCLE cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation. 3-Aminopropylene,3 Aminopropylene
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
September 2019, Bioorganic & medicinal chemistry letters,
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
April 1994, Farmaco (Societa chimica italiana : 1989),
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
February 2018, Molecules (Basel, Switzerland),
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
June 2000, Archiv der Pharmazie,
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
June 2010, European journal of medicinal chemistry,
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
December 2010, Bioorganic & medicinal chemistry letters,
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
January 1994, Farmaco (Societa chimica italiana : 1989),
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
November 2011, Chemical biology & drug design,
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
July 2013, Bioorganic & medicinal chemistry letters,
G C Porretta, and R Fioravanti, and M Biava, and M Artico, and A Villa, and N Simonetti
September 1988, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!